SRPT
Sarepta Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +7.7% ·
share flow -2.5% ·
net new positions +7.1%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 19.39K | $353,037 | n/a | −2 |
| Q2 2026 | 109 | +2 | 83.38M | $1.50B | +13 | −12 |
| Q1 2026 | 111 | +1 | 76.41M | $1.66B | +6 | −6 |
| Q4 2025 | 110 | +2 | 75.97M | $1.63B | +3 | n/a |
| Q3 2025 | 17 | 0 | 44.07M | $848.49M | +2 | −3 |
| Q2 2025 | 15 | -1 | 40.14M | $686.46M | +1 | −2 |
| Q1 2025 | 13 | -1 | 11.03M | $703.96M | +1 | −2 |
| Q4 2024 | 14 | -1 | 10.27M | $1.25B | +2 | −3 |
| Q3 2024 | 14 | +1 | 7.65M | $955.24M | +1 | n/a |
| Q2 2024 | 13 | n/a | 7.85M | $1.24B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.73M | +32.3% | $340.53M | 0.1% | ▲ Add | 2 | SEC ↗ ×8 |
| 2 | Geode Capital Management ✦ (passive) | 1.70M | +2.7% | $211.91M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 1.01M | +8.9% | $125.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 926.22K | +19.4% | $115.68M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Adage Capital Partners ✦ | 275.00K | -31.2% | $34.34M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 236.53K | -30.4% | $29.54M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 230.48K | -34.5% | $28.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Soros Fund Management ✦ | 206.58K | New | $25.80M | 0.7% | New | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 202.27K | -62.7% | $25.26M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 10 | Marshall Wace ✦ | 42.94K | -0.9% | $5.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 36.85K | -24.6% | $4.60M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 22.08K | -96.1% | $2.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 21.74K | -81.5% | $2.71M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 14 | Fisher Asset Management ✦ | 18.16K | +1.3% | $2.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Soros Fund Management | $25.80M | 0.7% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 339 holders, 102.41M shares, $2.16B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.